Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
1.00-<
EC/CAS
215-222-5/1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
<0.50
EC/CAS
215-691-6/1344-28-1
Name of the chemical
aluminium oxide
Concentration
10.00-<
EC/CAS
215-171-9/1309-48-4
Name of the chemical
magnesium oxide
Concentration
10.00-<
General Information
Version
3.1.0, issued
Revision date
2019-04-10
Product name
BegoForm (REF 52785)
1.2.1 Relevant identified uses
Manufacturing of dental prosthesis in a dental laboratory
Emergency telephone
For medical advice (in German and English
Icons in SDS
Company Information
company name
BEGO Bremer Goldschlägerei
e-mail address of the competent person responsible for the Safety Data Sheet
msds@bego.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373i
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification in accordance with
Classifications
This product is assessed and classified using the methods and criteria below referred to in Article 9 of Regulation (EC) n°
Physical hazards
determined through assessment data based on the methods or standards referred to in part 2 of Annex I to CLP
Health hazards
determined through toxicological and ecotoxicological assessment data based on the methods or standards referred to in Part 3, 4 and 5 of Annex I to CLP.
2.2 Label elements
Labelling
Hazard pictograms
GHS08
Signal word
Warning Hazardous component(s) to be indicated on label: Quartz (SiO2)
Hazard statements
H373i May cause damage to organs through prolonged or repeated exposure if inhaled.
Precautionary statements
P260 Do not breathe dust. P314 Get medical advice/attention if you feel unwell. P403+P233 Store in a well-ventilated place. Keep container tightly closed. Labelling information This product contains between 1% and 10% quartz (fine fraction) which is classified as STOT RE1.
2.3 Other hazards
Depending on the handling and use (eg. grinding, drying) formation of airborne respirable crystalline silica is possible. Prolonged and / or massive inhalation of respirable crystalline silica can cause silicosis disease (silicosis). Main symptoms of silicosis are cough and breathing problems / shortness of breath. In case of irregular exposure to respirable crystalline silica appropriate safety and surveillance measures should exist. The handling of the product should be carried out with special care in order to avoid dust formation. PBT assessment No data available. vPvB assessment No data available.